Lumateperone in schizophrenia: a profile of its use James E. Frampton Adis Drug Q&A 06 October 2020 Pages: 477 - 484
Upadacitinib in rheumatoid arthritis: a profile of its use Sean DugganSusan J. Keam Adis Drug Q&A 26 October 2020 Pages: 485 - 493
Olopatadine/mometasone combination nasal spray in allergic rhinitis: a profile of its use Yvette N. Lamb Adis Drug Q&A 27 September 2020 Pages: 494 - 501
Methadone is an option to treat cancer pain in carefully selected patients Caroline FentonKatherine A. Lyseng-Williamson Disease Management 02 September 2020 Pages: 502 - 508
The role of renin–angiotensin–aldosterone system inhibition in the regression of hypertensive left ventricular hypertrophy: the evidence of the last three decades Shah Newaz AhmedRatinder JhajRajnish Joshi Therapy in Practice 27 August 2020 Pages: 509 - 517
Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers Chia Siang KowSyed Shahzad Hasan Current Opinion 16 August 2020 Pages: 518 - 522
The COVID-19 pandemic threatens the Expanded Program on Immunization: recommendations for sustaining vaccination goals Husnain HamidTauqeer Hussain MallhiNoor ul Ain Commentary 05 September 2020 Pages: 523 - 525
Cosmetic disfigurement from black salve Lopa ThambiKaren KonkelLynda McCulley Commentary 26 September 2020 Pages: 526 - 528
Evaluation of the prescribing of proton pump inhibitors as stress ulcer prophylaxis for non-ICU patients in a Malaysian tertiary hospital Muhammad Eid AkkawiMohamed Hassan Elnaem Original Research Article 31 August 2020 Pages: 529 - 534